These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1730189)
1. A multicenter, open comparative study of parenteral cefotaxime and ceftriaxone in the treatment of nosocomial lower respiratory tract infections. Garber GE; Auger P; Chan RM; Conly JM; Shafran SD; Gerson M Diagn Microbiol Infect Dis; 1992 Jan; 15(1):85-8. PubMed ID: 1730189 [TBL] [Abstract][Full Text] [Related]
2. Cefotaxime versus ceftriaxone for the treatment of nosocomial pneumonia. Results of a multicenter study. Shah PM; Stille W Diagn Microbiol Infect Dis; 1995; 22(1-2):171-2. PubMed ID: 7587035 [TBL] [Abstract][Full Text] [Related]
3. Comparison of cefotaxime with ceftriaxone given intramuscularly 12-hourly for community-acquired pneumonia. Dansey RD; Jacka PJ; Strachan SA; Hay M Diagn Microbiol Infect Dis; 1992 Jan; 15(1):81-4. PubMed ID: 1730188 [TBL] [Abstract][Full Text] [Related]
4. [Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime]. Lanni N; Scaglione B Minerva Med; 1986 Mar; 77(9-10):317-9. PubMed ID: 3485265 [TBL] [Abstract][Full Text] [Related]
5. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection]. Gao B; Hu J; Deng W Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502 [TBL] [Abstract][Full Text] [Related]
6. Cefotaxime twice daily versus ceftriaxone once daily. A randomized controlled study in patients with serious infections. Simmons BP; Gelfand MS; Grogan J; Craft B Diagn Microbiol Infect Dis; 1995; 22(1-2):155-7. PubMed ID: 7587031 [TBL] [Abstract][Full Text] [Related]
7. Outcome of a ceftriaxone/cefotaxime interchange programme in a major teaching hospital. Gutensohn A; Bunz D; Frighetto L; Jewesson P Chemotherapy; 1991; 37 Suppl 3():15-21. PubMed ID: 1909228 [TBL] [Abstract][Full Text] [Related]
8. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study. Mandell LA; Bergeron MG; Ronald AR; Vega C; Harding G; Saginur R; Feld R; Duperval R; Landis SJ; Miedzinski LJ J Infect Dis; 1989 Sep; 160(3):433-41. PubMed ID: 2668427 [TBL] [Abstract][Full Text] [Related]
9. Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study. Abbate GF; Alagia I; Giaquinto E; Leonessa V; Savioli L; Altucci P; Caputi M; Guarino C; Micillo E; Catena E Respiration; 1986; 49(3):222-30. PubMed ID: 3515468 [TBL] [Abstract][Full Text] [Related]
10. Therapy of lower respiratory tract infections: a comparison of ceftriaxone and cefotaxime. Barradas P; Zamith M; Videira W; Cardosa T; Marques RA; Avila R Chemotherapy; 1989; 35 Suppl 2():33-40. PubMed ID: 2612238 [TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of ceftriaxone versus ceftazidime in the treatment of nosocomial lower respiratory tract infections. Bassetti D; Cruciani M; Solbiati M; Rubini F; Gandola L; Valenti G; De Palma M; Corda R; Carimeo N Chemotherapy; 1991; 37(5):371-5. PubMed ID: 1804598 [TBL] [Abstract][Full Text] [Related]
12. Study on the relationship between pharmacokinetics and antibacterial activity: comparison between ceftriaxone and cefotaxime within the respiratory tract. Fraschini F; Scaglione F Chemotherapy; 1989; 35(2):77-82. PubMed ID: 2758870 [TBL] [Abstract][Full Text] [Related]
13. Ceftriaxone compared with cefotaxime for serious bacterial infections. Smith CR; Petty BG; Hendrix CW; Kernan WN; Garver PL; Fox K; Beamer A; Carbone K; Threlkeld M; Lietman PS J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428 [TBL] [Abstract][Full Text] [Related]
14. Ceftriaxone therapy in adults with severe lower respiratory tract infections. Potgieter PD; Linton DM; Forder AA; Plumb H S Afr Med J; 1986 Apr; 69(8):495-7. PubMed ID: 3961646 [TBL] [Abstract][Full Text] [Related]
15. [Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections]. Martínez Jabaloyas JM; Sanz Chinesta S; Jiménez Cruz JF; Flores Corral N; Unda Urzaiz M; Leiva Galvis O; González Romojaro V; Hernández Fernández C; Lledó García E; Rioja Sanz LA; Gonzalvo Ibarra A; Camacho González JE; Ruíz Alvárez-Cienfuegos F; Resel Estévez L; Corral Saleta J; Burgos Rodríguez R; Del Rosal Samaniego JM Actas Urol Esp; 1997; 21(7):668-74. PubMed ID: 9412209 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of the combination of aztreonam with cefotaxime in the treatment of severe nosocomial pneumonia. Comparative study against amikacin combined with cefotaxime. Torres A; de Celis R; Rabinad E; Marco F; Almela M; Deulofeu R; Rodriguez-Roisin R; Agusti Vidal A Chemotherapy; 1989; 35 Suppl 1():15-24. PubMed ID: 2659289 [TBL] [Abstract][Full Text] [Related]
17. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections. Hirata-Dulas CA; Stein DJ; Guay DR; Gruninger RP; Peterson PK J Am Geriatr Soc; 1991 Oct; 39(10):979-85. PubMed ID: 1918785 [TBL] [Abstract][Full Text] [Related]
18. [Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections]. Regnier B Presse Med; 1989 Oct; 18(32):1617-21. PubMed ID: 2530546 [TBL] [Abstract][Full Text] [Related]